Data / Form D filings / KALIDEX PHARMACEUTICALS, INC.
KALIDEX PHARMACEUTICALS, INC.: Form D filings
KALIDEX PHARMACEUTICALS, INC., a pharmaceuticals company in Menlo Park, CA, filed 2 Form D notices with the SEC between 2010 and 2011. The latest, on March 9, 2011, reports $8.2 million sold of a $45 million offering to 8 investors.
Find out what KALIDEX PHARMACEUTICALS, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 70 WILLOW ROAD, SUITE 200, Menlo Park, CA, 94025
- Phone
- (650) 325-5156
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2010
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1505215
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 9, 2011 | New notice | $44,999,989 | $8,249,998 | $36,749,991 | 8 | Mar 1, 2011 | sec.gov |
| Nov 10, 2010 | New notice | $500,628 | $250,628 | $250,000 | 4 | Oct 28, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Dennis (Vernon) Podlesak | Director | |
| Brent (Vernon) Ahrens | Director | |
| Shelley (Vernon) Chu | Director | |
| Gary (Vernon) Patou | Director | |
| Patrick (Vernon) Heron | Director | |
| Yigong (James) Ge | Executive Officer, Director | |
| Ron (Vernon) Hunt | Director | |
| Chun (Vernon) Jiang | Executive Officer |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Mar 7, 2011 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what KALIDEX PHARMACEUTICALS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.